These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21487651)

  • 21. A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex.
    Marek GJ; Wright RA; Gewirtz JC; Schoepp DD
    Neuroscience; 2001; 105(2):379-92. PubMed ID: 11672605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prefrontal cortex and basolateral amygdala modulation of dopamine-mediated locomotion in the nucleus accumbens core.
    Rouillon C; Abraini JH; David HN
    Exp Neurol; 2008 Jul; 212(1):213-7. PubMed ID: 18501353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Group II metabotropic glutamate receptor modulation of DOI-induced c-fos mRNA and excitatory responses in the cerebral cortex.
    Zhai Y; George CA; Zhai J; Nisenbaum ES; Johnson MP; Nisenbaum LK
    Neuropsychopharmacology; 2003 Jan; 28(1):45-52. PubMed ID: 12496939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effects of Shati/Nat8l overexpression in the medial prefrontal cortex on methamphetamine-induced conditioned place preference in mice.
    Haddar M; Uno K; Azuma K; Muramatsu SI; Nitta A
    Addict Biol; 2020 May; 25(3):e12749. PubMed ID: 30950164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-Hydroxytryptamine2A (5-HT2A) receptor regulation in rat prefrontal cortex: interaction of a phenethylamine hallucinogen and the metabotropic glutamate2/3 receptor agonist LY354740.
    Marek GJ; Wright RA; Schoepp DD
    Neurosci Lett; 2006 Aug; 403(3):256-60. PubMed ID: 16759803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The selective metabotropic glutamate 2/3 receptor agonist MGS0028 reverses psychomotor abnormalities and recognition memory deficits in mice lacking the pituitary adenylate cyclase-activating polypeptide.
    Ago Y; Hiramatsu N; Ishihama T; Hazama K; Hayata-Takano A; Shibasaki Y; Shintani N; Hashimoto H; Kawasaki T; Onoe H; Chaki S; Nakazato A; Baba A; Takuma K; Matsuda T
    Behav Pharmacol; 2013 Feb; 24(1):74-7. PubMed ID: 23268987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Group II mGlu receptor agonists inhibit behavioural and electrophysiological effects of DOI in mice.
    Kłodzinska A; Bijak M; Tokarski K; Pilc A
    Pharmacol Biochem Behav; 2002 Sep; 73(2):327-32. PubMed ID: 12117586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of mGlu2/3 metabotropic glutamate receptors negatively regulates the stimulation of inositol phospholipid hydrolysis mediated by 5-hydroxytryptamine2A serotonin receptors in the frontal cortex of living mice.
    Molinaro G; Traficante A; Riozzi B; Di Menna L; Curto M; Pallottino S; Nicoletti F; Bruno V; Battaglia G
    Mol Pharmacol; 2009 Aug; 76(2):379-87. PubMed ID: 19439499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of social encounter-induced activation of prefrontal serotonergic systems in the abnormal behaviors of isolation-reared mice.
    Ago Y; Araki R; Tanaka T; Sasaga A; Nishiyama S; Takuma K; Matsuda T
    Neuropsychopharmacology; 2013 Jul; 38(8):1535-47. PubMed ID: 23426384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Actions of Group I and Group II metabotropic glutamate receptor ligands on 5-hydroxytryptamine release in the rat cerebral cortex in vivo: differential roles in the regulation of central serotonergic neurotransmission.
    Lee JJ; Croucher MJ
    Neuroscience; 2003; 117(3):671-9. PubMed ID: 12617971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute increases in monoamine release in the rat prefrontal cortex by the mGlu2/3 agonist LY379268 are similar in profile to risperidone, not locally mediated, and can be elicited in the presence of uptake blockade.
    Cartmell J; Perry KW; Salhoff CR; Monn JA; Schoepp DD
    Neuropharmacology; 2001 Jun; 40(7):847-55. PubMed ID: 11378155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AMPA receptor stimulation mediates the antidepressant-like effect of a group II metabotropic glutamate receptor antagonist.
    Karasawa J; Shimazaki T; Kawashima N; Chaki S
    Brain Res; 2005 Apr; 1042(1):92-8. PubMed ID: 15823257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: in vitro characterization of agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]-hexane-4,6-dicarboxylic acid (LY404039).
    Rorick-Kehn LM; Johnson BG; Burkey JL; Wright RA; Calligaro DO; Marek GJ; Nisenbaum ES; Catlow JT; Kingston AE; Giera DD; Herin MF; Monn JA; McKinzie DL; Schoepp DD
    J Pharmacol Exp Ther; 2007 Apr; 321(1):308-17. PubMed ID: 17204749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unraveling monoamine receptors involved in the action of typical and atypical antipsychotics on glutamatergic and serotonergic transmission in prefrontal cortex.
    López-Gil X; Artigas F; Adell A
    Curr Pharm Des; 2010; 16(5):502-15. PubMed ID: 19909228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of DOI-induced increases in cortical BDNF expression by group II mGlu receptors.
    Gewirtz JC; Chen AC; Terwilliger R; Duman RC; Marek GJ
    Pharmacol Biochem Behav; 2002 Sep; 73(2):317-26. PubMed ID: 12117585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of methamphetamine-induced hyperlocomotion in mice by clorgyline, a monoamine oxidase-a inhibitor, through alteration of the 5-hydroxytriptamine turnover in the striatum.
    Kitanaka N; Kitanaka J; Takemura M
    Neuroscience; 2005; 130(2):295-308. PubMed ID: 15664686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antipsychotic action of selective group II metabotropic glutamate receptor agonist MGS0008 and MGS0028 on conditioned avoidance responses in the rat.
    Takamori K; Hirota S; Chaki S; Tanaka M
    Life Sci; 2003 Aug; 73(13):1721-8. PubMed ID: 12875903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A role for noradrenergic transmission in the actions of phencyclidine and the antipsychotic and antistress effects of mGlu2/3 receptor agonists.
    Swanson CJ; Schoepp DD
    Ann N Y Acad Sci; 2003 Nov; 1003():309-17. PubMed ID: 14684454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of p/q-Ca2+ channels in metabotropic glutamate receptor 2/3-dependent presynaptic long-term depression at nucleus accumbens synapses.
    Robbe D; Alonso G; Chaumont S; Bockaert J; Manzoni OJ
    J Neurosci; 2002 Jun; 22(11):4346-56. PubMed ID: 12040040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropharmacological profiles of antagonists of group II metabotropic glutamate receptors.
    Kawashima N; Karasawa J; Shimazaki T; Chaki S; Okuyama S; Yasuhara A; Nakazato A
    Neurosci Lett; 2005 Apr; 378(3):131-4. PubMed ID: 15781145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.